Cholangitis primary prevention: Difference between revisions
Jump to navigation
Jump to search
| Line 9: | Line 9: | ||
*Treatment of [[gallstones]], [[tumors]], and infestations of parasites may reduce the risk for some people. | *Treatment of [[gallstones]], [[tumors]], and infestations of parasites may reduce the risk for some people. | ||
**A metal or plastic [[stent]] within the bile system may be needed to prevent recurrence. | **A metal or plastic [[stent]] within the bile system may be needed to prevent recurrence. | ||
*Patients with compromised [[biliary systems]] | *Patients with compromised [[biliary systems]] prone to developing recurrent cholangitis may benefit from antibiotic maintenance therapy, given daily in lower-than-therapeutic dosages.<ref name="pmid7986900">{{cite journal |vauthors=van den Hazel SJ, Speelman P, Tytgat GN, Dankert J, van Leeuwen DJ |title=Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis |journal=Clin. Infect. Dis. |volume=19 |issue=2 |pages=279–86 |year=1994 |pmid=7986900 |doi= |url=}}</ref> | ||
==References== | ==References== | ||
Revision as of 19:46, 13 September 2016
|
Cholangitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cholangitis primary prevention On the Web |
|
American Roentgen Ray Society Images of Cholangitis primary prevention |
|
Risk calculators and risk factors for Cholangitis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farwa Haideri [2]
Overview
Although reestablishing biliary drainage is the mainstay of treatment, antibiotics play an important role in the management of cholangitis.
Primary Prevention
- Treatment of gallstones, tumors, and infestations of parasites may reduce the risk for some people.
- A metal or plastic stent within the bile system may be needed to prevent recurrence.
- Patients with compromised biliary systems prone to developing recurrent cholangitis may benefit from antibiotic maintenance therapy, given daily in lower-than-therapeutic dosages.[1]